Cartesian Therapeutics Inc
NASDAQ:RNAC
Cartesian Therapeutics Inc
NASDAQ:RNAC
Price:
6.41
USD
-7.37%
Market Cap:
$188.3m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Cartesian Therapeutics Inc
NASDAQ:RNAC
|
US |
|
Darma Henwa Tbk PT
IDX:DEWA
|
ID |
|
P
|
PCBL Ltd
BSE:506590
|
IN |
|
Applovin Corp
NASDAQ:APP
|
US |
|
M
|
MultiChoice Group Ltd
JSE:MCG
|
ZA |
|
Applied DNA Sciences Inc
NASDAQ:BNBX
|
US |
|
Intertrust NV
F:4IT
|
NL |
|
N
|
Nextera Energy Inc
SWB:FP3
|
US |
|
Metro Bank PLC
LSE:MTRO
|
UK |
|
Chemed Corp
NYSE:CHE
|
US |
|
Wall Financial Corp
TSX:WFC
|
CA |
|
B
|
BNP Paribas SA
OTC:BNPQF
|
FR |
|
Hercules Capital Inc
LSE:0J4M
|
US |
|
Saia Inc
NASDAQ:SAIA
|
US |
|
Hallenstein Glasson Holdings Ltd
NZX:HLG
|
NZ |
|
Mind Medicine (MindMed) Inc
NASDAQ:MNMD
|
CA |
|
Genesis AI Corp
OTC:AIGFD
|
CA |
|
Steel Dynamics Inc
NASDAQ:STLD
|
US |
|
Amber Enterprises India Ltd
NSE:AMBER
|
IN |
|
Fresenius Medical Care AG
XMUN:FME
|
DE |
|
U
|
United Bankshares Inc
NASDAQ:UBSI
|
US |
|
K
|
Konan Technology Inc
KOSDAQ:402030
|
KR |
|
A
|
Abl Group ASA
OSE:ABL
|
NO |
|
B
|
Brainchip Holdings Ltd
OTC:BRCHF
|
AU |
DCF Valuation
is not available for Cartesian Therapeutics Inc
is not available for Cartesian Therapeutics Inc
RNAC's DCF value cannot be reliably calculated.
Switch to
See Also
Other Cartesian Therapeutics Inc listings:
Discover More
